Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Aura Biosciences, Inc. (AURA) had Normalized Pre-Tax Income of $-26.10M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-26.13M |
|
-- |
|
-- |
|
$27.91M |
|
$-27.91M |
|
$1.80M |
|
$-26.10M |
|
|
Normalized Pre-Tax Income |
$-26.10M |
$-26.13M |
|
$-26.13M |
|
$-26.13M |
|
$-26.13M |
|
$-27.91M |
|
$-27.63M |
|
65.94M |
|
65.94M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$170.12M |
|
$2.63M |
|
$19.90M |
|
$190.02M |
|
$18.82M |
|
-- |
|
$14.53M |
|
$33.36M |
|
$156.67M |
|
$156.67M |
|
$156.67M |
|
62.99M |
|
| Cash Flow Statement Financials | |
$-64.27M |
|
$5.77M |
|
$74.39M |
|
$32.46M |
|
$48.32M |
|
$15.86M |
|
$11.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.68% |
|
-16.68% |
|
-13.75% |
|
-16.68% |
|
$2.49 |
|
$-0.98 |
|
$-0.97 |
|